Zacks Research Has Strong Forecast for PAHC FY2026 Earnings

Key Points

• Zacks Research has increased its FY2026 earnings per share estimate for Phibro Animal Health to $2.19, up from a previous forecast of $2.18, while the current consensus estimate stands at $1.95 per share.
• Phibro Animal Health recently declared a quarterly dividend of $0.12 per share, reflecting an annualized yield of 1.7% with a payout ratio of 61.54%.
• The company's stock is currently rated as a "Hold" with a consensus target price of $24.40, following various upgrades from multiple financial analysts in recent weeks.

Phibro Animal Health Corporation (NASDAQ:PAHC - Free Report) - Research analysts at Zacks Research boosted their FY2026 earnings per share estimates for shares of Phibro Animal Health in a report released on Wednesday, August 6th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $2.19 per share for the year, up from their previous forecast of $2.18. The consensus estimate for Phibro Animal Health's current full-year earnings is $1.95 per share. Zacks Research also issued estimates for Phibro Animal Health's Q4 2026 earnings at $0.69 EPS, Q4 2027 earnings at $0.64 EPS and FY2027 earnings at $2.34 EPS.

PAHC has been the topic of several other reports. Wall Street Zen upgraded shares of Phibro Animal Health from a "hold" rating to a "buy" rating in a report on Friday, May 9th. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a "neutral" rating to an "overweight" rating and increased their price objective for the stock from $25.00 to $35.00 in a research report on Monday, July 7th. BNP Paribas Exane raised Phibro Animal Health from an "underperform" rating to a "neutral" rating and set a $24.00 target price on the stock in a research report on Monday, June 16th. Morgan Stanley set a $26.00 price target on shares of Phibro Animal Health and gave the stock an "equal weight" rating in a research note on Wednesday, June 25th. Finally, BNP Paribas upgraded shares of Phibro Animal Health to a "hold" rating in a report on Monday, June 16th. Two research analysts have rated the stock with a sell rating, three have given a hold rating and two have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of "Hold" and a consensus target price of $24.40.

Phibro Animal Health Trading Up 1.9%

PAHC stock traded up $0.51 during midday trading on Friday, hitting $27.84. 32,418 shares of the company's stock were exchanged, compared to its average volume of 257,178. Phibro Animal Health has a 1-year low of $16.16 and a 1-year high of $31.80. The business has a 50-day simple moving average of $26.91 and a two-hundred day simple moving average of $23.45. The stock has a market capitalization of $1.13 billion, a PE ratio of 35.66, a P/E/G ratio of 0.44 and a beta of 0.80. The company has a current ratio of 2.91, a quick ratio of 1.23 and a debt-to-equity ratio of 2.67.

Phibro Animal Health (NASDAQ:PAHC - Get Free Report) last issued its earnings results on Wednesday, May 7th. The company reported $0.63 EPS for the quarter, topping analysts' consensus estimates of $0.52 by $0.11. The company had revenue of $347.80 million for the quarter, compared to the consensus estimate of $352.41 million. Phibro Animal Health had a net margin of 2.68% and a return on equity of 30.51%.

Institutional Trading of Phibro Animal Health

Several institutional investors and hedge funds have recently bought and sold shares of PAHC. Point72 Asia Singapore Pte. Ltd. acquired a new stake in shares of Phibro Animal Health in the fourth quarter valued at about $29,000. National Bank of Canada FI purchased a new position in Phibro Animal Health in the first quarter valued at approximately $30,000. Financial Management Professionals Inc. acquired a new stake in shares of Phibro Animal Health in the second quarter valued at about $32,000. Lazard Asset Management LLC lifted its holdings in Phibro Animal Health by 2,739.7% in the 4th quarter. Lazard Asset Management LLC now owns 1,647 shares of the company's stock worth $34,000 after buying an additional 1,589 shares in the last quarter. Finally, Aquatic Capital Management LLC bought a new stake in shares of Phibro Animal Health in the fourth quarter worth $69,000. Hedge funds and other institutional investors own 99.34% of the company's stock.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, September 24th. Investors of record on Wednesday, September 3rd will be paid a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a yield of 1.7%. The ex-dividend date is Wednesday, September 3rd. Phibro Animal Health's dividend payout ratio (DPR) is currently 61.54%.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.